
The Vanderbilt Professor of Preventive Medicine shares thoughts on the first potential COVID-19 vaccine, at a time of record new daily cases.

The Vanderbilt Professor of Preventive Medicine shares thoughts on the first potential COVID-19 vaccine, at a time of record new daily cases.

A glimpse into FDA advisor perspective just weeks before EUAs are anticipated to be sent.

A vaccine developer joins for a firsthand discussion on the development, research, and distribution process.

The Meharry and Vanderbilt-based expert shares insights into reaching less trustful populations on the first podcast episode.

Learn what Cidara Therapeutics has in development in this episode of Contagion® Connect.

In this episode, our guests compare the West African Ebola outbreak to the ongoing outbreak in the Democratic Republic of the Congo.

In 2010, Timothy Ray Brown came forward as the "Berlin Patient" and has become an advocate for people living with HIV. He hopes to see the day when all individuals when HIV can be cured safely.

Paul Abrams, MBA, director of Health Care Specialty Group at MJH Life Sciences, spoke to Vaibhav Singh from Circle of Life about Zevac, a tool that aims to help clinicians make more informed prescribing decisions.

In this episode, we take a dual look at the recently announced changes to antibiotic reimbursements from the Centers for Medicare and Medicaid Services from both the clinician and industry perspective.

The first Contagion® Connect podcast features a conversation with Dr. Alexandra Phelan about the impact of pandemic bonds in the ongoing Ebola outbreak in the DRC.